Sukumar Nagendran, President and Head of R&D: Taysha Gene Therapies TSHA Buy · Filed 23/05/18

Trade details

Type: Insider buy
Amount: $3,400
Shares · price: 5,000 sh · $0.68 a share
Held after: 34,226 sh
Stock: Taysha Gene Therapies TSHA
Person: Sukumar NagendranPresident and Head of R&D
Trade date: 23/05/16
Filed: 23/05/18
Days to filing: 2 days

Holdings up 17.1%

Insiders buying this week: 1 insiders
Holding change: +17.1%

Taysha Gene Therapies trades, last 26 weeks

What else happened in Taysha Gene Therapies around then

Filed or reported within 30 days of the trade day · 23/04/16~23/06/15

Sukumar Nagendran's recent trades

Sukumar NagendranOfficer
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 plan
Taysha Gene Therapies
TSHA
$1.3M
200,000 sh
$1.3M
Filed 07/10
Traded 07/10
Sukumar NagendranPresident and Head of R&D
Sell10b5-1 planTaysha Gene Therapies
Sell10b5-1 plan
Taysha Gene Therapies
TSHA
$892K
200,000 sh
$892K
Filed 04/13
Traded 04/10
Sukumar NagendranOfficer
Planned sale10b5-1 planTaysha Gene Therapies
Planned sale10b5-1 plan
Taysha Gene Therapies
TSHA
$926K
200,000 sh
$926K
Filed 04/10
Traded 04/10
Sukumar NagendranPresident and Head of R&D
SellTaysha Gene Therapies
Sell
Taysha Gene Therapies
TSHA
$423.4K
89,132 sh
$423.4K
Filed 01/27
Traded 01/23
Sukumar NagendranPresident and Head of R&D
SellTaysha Gene Therapies
Sell
Taysha Gene Therapies
TSHA
$124.1K
26,918 sh
$124.1K
Filed 01/27
Traded 01/26